A Study to Evaluate Comparative Bioavailability of BMS-986278 in Healthy Participants

NCT06715683 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: BMS-986278 Batched method, Dose A
DRUG: BMS-986278 Batched method, Dose B
DRUG: BMS-986278 Continuous method

Sponsor

Bristol-Myers Squibb